Search Results

We are thrilled to announce the election of three new officers to the ERGA Executive Board ! Tyler Alioto, Kay Lucek, and Stefaniya Kamenova have been appointed as Scientific, Partnership, and Dissemination Officers, respectively. Tyler, Kay and Stefaniya have been active members of our community, demonstrating commitment and strong engagement across various ERGA committees. Their participation on the Executive Board will bring valuable new perspectives — we wish them great success in their new roles! This marks the fourth iteration of ERGA Executive Board elections, now a well-established process. The procedure was followed closely by the ERGA Council, in accordance with the guidelines established by the ERGA Governance Document .  The process also received crucial oversight from the Nominations Working Group and support from the Elections Supporting Team (Christian de Guttry, Diego de Panis and João Pimenta). The ERGA Executive Board includes a total of nine representatives with different roles. We thank the outgoing officers Rosa Fernández, Elena Bužan, and Chiara Bortoluzzi for their outstanding work and contributions during their time on the Executive Board! Learn more about these three officer roles: Partnership Officer Builds and steers collaborations with infrastructures, initiatives, and agencies; aligns joint work plans; supervises MoUs/data-sharing; co-develops multi-partner proposals; connects National Nodes with external partners. Dissemination Officer Ensures ERGA outputs are FAIR and visible; coordinates publications, datasets/DOIs, licences, and metadata; works with Comms, website/newsletter/social channels; supports GoaT alignment and cross-committee showcases. Scientific Officer Leads scientific direction and harmonisation; maintains roadmap from sampling to analysis; oversees SOPs, benchmarking, and compliance (open data, licences, ABS/Nagoya); coordinates across SSP, SAC, DAC, and ITIC.

The European Reference Genome Atlas ( ERGA ) and the European node of the International Barcode of Life ( iBOL Europe ), two international communities of scientists brought together under the Biodiversity Genomics Europe  Project, are joining forces for “Connections,” a series of blog posts that explore the fascinating world of Biodiversity Genomics  and the intersection of their communities. If you have been following our Connections series so far, you have learned that barcodes help us recognise which “book” of life we are holding, while reference genomes let us read every page. Today, we follow those pages out of the lab into the places where decisions are made. Biodiversity genomics has matured from proof-of-concept to a toolkit that can inform, for example, monitoring, species risk assessment, and management, and even market rules, by turning reads and assemblies into actions that matter for species, habitats, and the people depending on them. The impact pathway usually begins with identification and baselines. DNA barcodes establish who is where. This matters when regulators need quick and reliable evidence to tighten protection for a declining bird population in a wetland. Or when managers must separate look-alike pest species in aquaculture, or when coastal engineers test whether a beach-nourishment scheme is compatible with an endemic fish. Reference genomes deepen the story. They reveal how a species works, what its population structure is, connectivity, and adaptive variation. All clues that tell us if a population can, for instance, cope with heatwaves, if a corridor is worth restoring, and which individuals should contribute to an ex-situ programme. In other words, barcodes inform us of their presence, and genomes explain how they function. Consider fisheries and seafood safety. Genomics applied to widely fished pelagic species can clarify stock boundaries, helping fish stock management plans align with biology rather than old assumptions. At the same time, genomics in commercially harvested clams can support contamination assessment risks more precisely, so that consumer guidance and coastal policies rest on data rather than speculations. In both cases, genomics can improve sustainability and trust: what gets caught, what gets sold, what gets eaten, and what the sea can afford to give. Public health is another frontier where decisions move at the speed of evidence. Genomics of mosquito complexes that transmit West Nile virus allows us to identify cryptic lineages and chemosensory genes tied to behaviour, turning a confusing species complex into a map for outbreak monitoring programmes. From these insights, SNP panels for routine surveillance, early detection of resistance to control measures, and area-specific interventions mandated by regional authorities can be designed. On land, genomics can inform connectivity, reintroduction, and hybridisation policies. For example, in a rare Central European small mammal, its genomic structure showed how a modern drainage canal severed gene flow. The management recommendation is to restore corridors before populations slip past recovery. Alpine chamois and butterflies reveal country-level patterns of diversity and endemism. These data now feed directly into status reviews and legally binding conservation lists. In lowland wetlands, a long-distance migratory passerine with low diversity but ongoing gene flow gains a genetic monitoring plan that guides translocation choices and post-release tracking. Where climate change pushes related hare species into contact, genomic portraits of introgression help hunting and wildlife agencies adjust seasons and safeguards to protect vulnerable mountain lineages. Plants illustrate the same arc from data to decision. Herbs harvested from the wild, dune shrubs that stabilise coasts, and aromatic species adapting to new climates all benefit from genome-enabled surveys that distinguish clonal spread from sexual reproduction, estimate contemporary effective size, and pinpoint variants tied to heat and frost. These findings shape seed-sourcing, habitat management, and Europe-wide genetic monitoring comparable across borders, museums, and herbaria. What ties these stories together is not a single technology, but a way of working. Barcodes and genomes are generated in collaboration with end-users, including park services, fishery bodies, health authorities, farmers, and NGOs. Data are paired with training, screening tools, and communication adapted to local contexts. This results in a lasting impact that takes many forms, from field measurements to management plans, from genome browsers to policy briefs, and from classroom demonstrations to community-run surveys. The book metaphor keeps us honest. Barcodes still tell us which titles we are holding, and reference genomes still let us read every page. But conservation impact starts when we file that book in the right library. We share it with the people who need it and use it to guide choices about land, water, and livelihoods. Biodiversity genomics is now doing exactly that, moving from pages to policies, with benefits that go far beyond the lab bench.

elsi@erga-biodiversity.eu < Back ELSI - Ethical, Legal, and Social Issues elsi@erga-biodiversity.eu The Ethical, Legal, and Social Issues (ELSI) Committee is committed to assisting ERGA in understanding and implementing international guidelines and standards and regional d Digital Sequence Information (DSI) frameworks. Monitoring ethical and legal issues, the committee plays a role in developing best practices for access and benefit sharing, data governance, and wider policy discussions. In practice, ELSI’s efforts include establishing governance frameworks for genomic data collection, management, and sharing in order to ensure that ERGA’s work is consistent with continually changing regulations and ethical standards. The committee supports compliance by providing practical assistance to ERGA researchers through resources, training sessions, and policy insights. Central to this is the committee's dedication to transparency, building trust, and encouraging ethical research in biodiversity genomics. (V.3.0 01.12.2025) Chair Jennifer Leonard Coordinator Christian de Guttry Steering Committee Rebekah Oomen Robert Waterhouse Elena Buzan Amber Hartman Scholz Camila Mazzoni Resources ▶️ Webinar: A Primer on Science Policy for Biodiversity Research Welcome to the new members of the ERGA Executive Board! Press Releases Connections #9: How Biodiversity Genomics drives conservation impact ERGA News #32 - November 2025

ERGA Registration Form

Social Justice Committee Social Justice Committee Definition Generating high-quality eukaryotic reference genomes is transforming our understanding of biology and evolution. The process of developing this resource so that it has long-term utility is complex and intricate, requiring not only technical and scientific expertise but also the integration of social justice principles. These data will have a significant impact on society, making the incorporation of social justice principles essential. In the ERGA community research setting, social justice means treating everyone fairly and ensuring that individuals from all backgrounds can benefit from our research. Key components of this process include diversity in research participation, fair distribution of research benefits, adherence to high ethical standards, dissemination of research findings to a broad audience, and fostering an inclusive and supportive research environment. The ERGA Social Justice Committee is dedicated to embedding justice, equity, diversity, and inclusion principles into every aspect of eukaryotic genome production, from sampling to results dissemination. This committee serves as an ethical compass for ERGA members, guiding the community to ensure that every step in the genome generation pipeline is conducted with social responsibility and respect for diversity. We aim to ensure both scientific rigor and social responsibility in our guidelines for generating high-quality reference genomes by integrating these principles. Authors in alphabetical order Chiara Bortoluzzi, Christian de Guttry, James Fleming, Fabrizio Ghiselli, Jennifer Leonard, Rebekah Oomen Objectives Promoting Diversity In ERGA, diversity is multifaceted, encompassing the composition of research teams with individuals from diverse backgrounds and expertise, the variety of taxa sequenced and their geographical origins, as well as the involvement of stakeholders and citizen scientists. This approach ensures research methodologies and outcomes reflect nature's extensive diversity. Ensuring Equity Equity in ERGA is about providing equal access to resources and opportunities across all individuals, communities, countries, and research institutions. It particularly aims to include those historically underrepresented or marginalised. Transfer of Knowledge is integral to this effort, ensuring broad participation in this research. Advancing Inclusion Inclusion involves creating a research environment that values and welcomes the contributions of all, aiming to promote a setting in which every participant can thrive and deliver their maximum potential. To achieve this, we focus on enhanced communication tools, aiming to ensure everyone feels comfortable and supported. Upholding Justice ensuring genomic research processes are available to interested researchers. It also means recognizing and addressing traditional social inequalities affecting current research practices. Application in High-Quality Reference Genome Generation Diversity Sequencing: Allocate sequencing capacity to underrepresented taxa to broaden biodiversity knowledge. Collaboration: Establish diverse consortia to ensure broad geographic representation in genomic research initiatives. Promote gender equality in research teams and leadership positions within genomic projects. Outreach: Develop educational materials on genomics tailored to different academic backgrounds, ages, cultures, and languages. Equity Sample collection : Ensure equitable access to the benefits from genetic resources for source countries and communities, in line with the Access and Benefit Sharing framework (ABS) and the Nagoya Protocol. Ensuring, where possible, equitable access to the field for researchers with diverse needs. Wet lab: Partner with local labs in sample-origin countries to build capacity and share expertise. Sequencing : Offer training programs and protocol sharing in sequencing techniques for scientists from all backgrounds. Genome assembly: Provide open-source software and pipelines together with cloud-based computational resources for researchers who need access to bioinformatic support and computing power. Publishing : Encourage open access availability, either through open access publication or deposition of versions of papers in open access repositories. Technology transfer: Facilitate the transfer of cutting-edge genomic technologies to laboratories in low-income countries; Provide legal and technical assistance to navigate regulations. Inclusion Sample collection: Implement informed consent protocols that respect Indigenous and local communities' rights and traditions. Empower the efforts of local taxonomic experts alongside those communities throughout the sample collection process. Publishing: Adopt open-access policies for publishing results, making information freely available to the community as soon as possible. Data sharing: Facilitate and encourage the rapid sharing of data in global databases that are freely accessible and FAIR (Findable, Accessible, Interoperable, and Reusable), promoting data democracy. Capacity building: Establish mentorship programs connecting established scientists with emerging European-based researchers. In this way, we aim to encourage the development of a new generation of scientists with a representative and diverse mix of abilities, genders, ethnicities, cultural and economic backgrounds, and geographical origins. Community engagement: Acknowledging the diverse contributions made beyond those in academia - universities/ museums/ research institutions - particularly those from local communities and underrepresented groups at all steps of the process from sampling to genome generation and appropriately recognizing their participation. Outreach: Host public science events in biodiversity genomics in diverse geographical locations to spread awareness and foster interest. Ensuring scientific events are organised in a way that is inclusive and accessible, both physically and socially. Social Justice Relevance: Acknowledging that both research and its outcomes could disproportionately affect specific communities within Europe, we commit to responsibly using outreach, engagement, and communication channels to center local communities impacted by biodiversity loss and anthropogenic environmental change, which are directly addressed in the ERGA remit. Personal data sharing: Ensure that data-sharing practices respect the privacy and rights of individuals and communities represented in the data. Ethics: Regularly review external bodies' ethical guidelines to address emerging issues related to social justice in genomics and strive to position ERGA to be as inclusive as possible. Sustainability: Research and implement sustainable laboratory and computational practices to reduce waste and energy consumption; Evaluate the long-term environmental impact of genomic research activities and develop strategies to mitigate negative effects. Conclusion Achieving the broad goals of social justice, diversity, equity, and inclusion in genomic research presents significant challenges. One major hurdle is the intrinsic resource and infrastructure disparities across different European regions. This discrepancy limits access to advanced genomic technologies, computational resources, and skilled personnel. This widens the gap between well-funded institutions in Strengthening countries and less-funded ones in Widening countries. It is also imperative to note that the historical underrepresentation of some groups and species in genomic studies poses ethical and logistical challenges when redressing these imbalances. The complexities of integrating diverse biological samples, especially from Indigenous and marginalised communities, require sensitive, informed consent processes and benefit-sharing arrangements that respect both legal frameworks and ethical considerations. Furthermore, incorporating a wide range of species and their geographical origins into research necessitates a collaborative effort, which geopolitical, financial, and linguistic barriers can hamper. There are as many solutions to these challenges as there are issues themselves. Fostering international collaborations sharing resources, knowledge, and skills is a key strategy for building capacity in underrepresented regions and marginalised groups. Initiatives like cloud-based computational resources, open-source software, and open-access publishing models can democratise access to genomic research tools and findings. Furthermore, engaging local communities in the research process, from planning through to publication, ensures that projects are culturally sensitive and ethically sound, while also facilitating the equitable sharing of benefits. Education and outreach, tailored to diverse audiences, can raise awareness and foster a more inclusive next generation of genomic researchers. Ultimately, the path to achieving Social Justice in genomic research is ongoing and requires a commitment to continuous reflection, adaptation, and action towards these ideals.